Neo Products
Calmark Neo - the platform
Calmark has developed a point-of-care (POC) diagnostic instrument to make measuring biomarkers for medical conditions in newborns easier and faster. The measuring instrument can document and measure results on the premises, in close proximity to the patient. The POC platform consists of an instrument and single-use test cassettes that are placed into the instrument during measurement.
The test cassette consists of a separate chamber in which the blood sample is placed. When the lid of the instrument closes, the test is activated and the blood sample reaches the filter design. Some of the filters are permeated with chemicals, which react with the relevant substance and produce a color change. This sequence of events takes place in a matter of a few minutes and is patented by the Calmark.
POC-Analyzer
Calmark POC-Analyzer is a portable, battery-powered and self-instructional instrument that will work with Calmark's POC test cassettes. Each test contains the information required for automatic calibration of the results. When closing the lid of the instrument, the test is activated and a numeric value is presented on the display.
Blood samples may be analyzed wherever the patient is located, eg. return visit at the birth clinic or at the maternity ward. The platform is adapted for hospital environment and is intended for in vitro diagnostics.
- Safe and easy to use
- The test results will appear on the screen within minutes
- Battery capacity: eight working hours, charged with micro-USB connector, charger included
- Data storage: 25 results are stored locally in the instrument
- Calibrated during manufacturing and does not need to be further calibrated
Neo-Bilirubin
Calmark Neo-Bilirubin quantitatively measures the concentration of bilirubin in whole blood of newborns and is used together with Calmark POC-Analyzer.
- Fast and quantitative measurement of bilirubin
- Optimized for accurate analysis with just a few drops of blood
- Measurement range 150-500 µmol / L (9-29 mg / dL)
- No interference from hemolysis up to 2 g/L
- Accurate results at up to 60% hematocrite
Patents